Search Within

Ross Levine

Formats
  1. Journal Article (388)
  2. Meeting Abstract (344)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (11)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (778)
  2. Center for Hematologic Malignancies (778)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (778)
  4. Department of Medicine (778)
  5. Executive Committee, Center for Hematologic Malignancies (778)
  6. GSK Faculty (778)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (72)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (9)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (108)
  3. American Association for Cancer Research (67)
  4. Cell Press (48)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (23)

More Publishers

Results (778)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Azacitidine, venetoclax, and revumenib for newly diagnosed NPM1-mutated or KMT2A-rearranged AML
    Journal Article

    Zeidner, J. F.; Lin, T. L.; Welkie, R. L.; Curran, E.; Koenig, K.; Stock, W.; Madanat, Y. F.; Swords, R.; Baer, M. R.; Blum, W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Journal Article

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Loghavi, S.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; more...
    Cell Stem Cell (2025)

    Fulltext@MSK | Save
  • Mutant IDH1 cooperates with NPM1c or FLT3(ITD) to drive distinct myeloid diseases and molecular outcomes
    Journal Article

    Sakamoto, T.; Leca, J.; Zhang, X.; Meydan, C.; Foox, J.; Ramachandran, P.; Hendrikse, L. D.; Zhou, W.; Berger, T.; Fortin, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on solid tumor progression following radiation therapy
    Journal Article

    Tao, J. J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: A report from the Beat AML clinical trial
    Research Letter

    Hoff, F. W.; Huang, Y.; Welkie, R. L.; Swords, R. T.; Traer, E.; Stein, E. M.; Lin, T. L.; Patel, P. A.; Collins, R. H. Jr; Baer, M. R.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
    Meeting Abstract

    Kunimoto, H.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; Toya, T.; Harada, Y.; Doki, N.; more...
    Cancer Science (2025)

    Fulltext@MSK | Save
  • Transcriptional activation of regenerative hematopoiesis via microenvironmental sensing
    Journal Article

    Itkin, T.; Houghton, S.; Schreiner, R.; Lin, Y.; Badwe, C. R.; Voisin, V.; Murison, A.; Seyedhassantehrani, N.; Kaufmann, K. B.; Garcia-Prat, L.; more...
    Nature Immunology (2025)

    Fulltext@MSK | Save
  • Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)
    Editorial

    Schmitz, K. H.; Brown, J. C.; Irwin, M. L.; Robien, K.; Scott, J. M.; Berger, N. A.; Caan, B.; Cercek, A.; Crane, T. E.; Evans, S. R.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of 28-day (Arm A) versus 14-day (Arm B) schedule of venetoclax + azacitidine in newly diagnosed acute myeloid leukemia patients ≥ 60 years
    Meeting Abstract

    Borate, U.; Huang, Y.; Zeidner, J. F.; Swords, R. T.; Koenig, K. L.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; more...
    Blood (2024)

    Fulltext@MSK | Save